Article

Week in Review: September 9, 2017

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Related Videos
Woman experiencing pain related to recurrent pericarditis -- Image credit: Art_Photo | stock.adobe.com
Pharmacist assisting a patient with pericarditis -- Image credit: Yuri Arcurs/peopleimages.com | stock.adobe.com
Patient receiving diabetes consultation -- Image credit: Syda Productions | stock.adobe.com
California Wildfires, Pharmacies, Community | image Credit: J Bettencourt/peopleimages.com | stock.adobe.com
California Wildfire, Pharmacy, Community | Image Credit: Erin | stock.adobe.com
Related Content
Amlodipine tablets | Image Credit: © Ming - stock.adobe.com
February 21st 2025

A Common Blood Pressure Medication May Help Treat Symptoms of ADHD

Alexandra Gerlach, Associate Editor
Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients
January 31st 2025

Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients

Luke Halpern, Assistant Editor
FDA approval stamp for chenodiol -- Image credit: Olivier Le Moal | stock.adobe.com
Published: February 21st 2025 | Updated: February 21st 2025

Chenodiol, First Treatment for Cerebrotendinous Xanthomatosis, Receives FDA Approval

Gillian McGovern, Associate Editor
Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health
December 24th 2024

Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health

Christina M. Madison, PharmD, FCCP, AAHIVP
Portrait of a happy African American pharmacist writing prescription at workplace in modern pharmacy - Image credit: sofiko14 | stock.adobe.com
February 21st 2025

Technicians Can Take Greater Ownership Over Billing and Reimbursement

Laura Nolan, CPHT, CSPT Jeannette Y. Wick, MBA, RPh, FASCP
Ozempic injection pens | Image Credit: © Natalia - stock.adobe.com
February 20th 2025

Study Shows Semaglutide Holds Promise in Reducing Alcohol Cravings

Alexandra Gerlach, Associate Editor